FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 30 filers reported holding FUSION PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,909,234 | -44.3% | 734,321 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $3,429,279 | +23.9% | 734,321 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,768,390 | +19.7% | 734,321 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,313,111 | +4.7% | 734,321 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,210,000 | +20.9% | 734,321 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $1,828,000 | -67.5% | 734,321 | 0.0% | 0.00% | -62.5% |
| Q1 2022 | $5,627,000 | +66.4% | 734,321 | 0.0% | 0.01% | +33.3% |
| Q4 2021 | $3,381,000 | -42.1% | 734,321 | 0.0% | 0.01% | -45.5% |
| Q3 2021 | $5,843,000 | -1.5% | 734,321 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $5,933,000 | -24.4% | 734,321 | 0.0% | 0.01% | -35.3% |
| Q1 2021 | $7,850,000 | – | 734,321 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,140,000 | 2.34% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $3,887,000 | 1.96% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,340,000 | 1.91% |
| Sio Capital Management, LLC | 260,448 | $649,000 | 0.24% |
| Orbimed Advisors | 3,224,770 | $8,030,000 | 0.15% |
| Artal Group S.A. | 750,000 | $1,868,000 | 0.10% |
| TPG GP A, LLC | 2,551,794 | $6,354,000 | 0.10% |
| Perceptive Advisors | 1,052,445 | $2,621,000 | 0.08% |
| Rock Springs Capital Management LP | 809,854 | $2,017,000 | 0.06% |
| FEDERATED HERMES, INC. | 3,124,100 | $7,779,000 | 0.02% |